Cipla to launch cinacalcet hydrochloride tablets in US.
Cipla said, its cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg) is generic therapeutic equivalent version of Sensipar, a branded drug marketed by Amgen Inc.
The launch, however, is a subject of ongoing litigation, Cipla said in a regulatory filing. Photo: PTI